These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21044144)

  • 21. Prolonged-release melatonin for children with neurodevelopmental disorders.
    De Leersnyder H; Zisapel N; Laudon M
    Pediatr Neurol; 2011 Jul; 45(1):23-6. PubMed ID: 21723455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Question 1: in a child with epilepsy, does melatonin affect the seizure threshold?
    Banerjee S; Kumar V
    Arch Dis Child; 2013 Aug; 98(8):642-4. PubMed ID: 23846356
    [No Abstract]   [Full Text] [Related]  

  • 23. Working under daylight intensity lamp: an occupational risk for developing circadian rhythm sleep disorder?
    Doljansky JT; Kannety H; Dagan Y
    Chronobiol Int; 2005; 22(3):597-605. PubMed ID: 16076658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.
    Wade AG; Ford I; Crawford G; McMahon AD; Nir T; Laudon M; Zisapel N
    Curr Med Res Opin; 2007 Oct; 23(10):2597-605. PubMed ID: 17875243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of sleep and circadian disturbances in urinary 6-sulphatoxymelatonin levels, on cognitive function after major surgery.
    Gögenur I; Middleton B; Burgdorf S; Rasmussen LS; Skene DJ; Rosenberg J
    J Pineal Res; 2007 Sep; 43(2):179-84. PubMed ID: 17645696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Add-on melatonin improves quality of life in epileptic children on valproate monotherapy: a randomized, double-blind, placebo-controlled trial.
    Gupta M; Aneja S; Kohli K
    Epilepsy Behav; 2004 Jun; 5(3):316-21. PubMed ID: 15145300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin (6 mg) or placebo for sleep disturbance and depressed mood.
    Serfaty MA; Osborne D; Buszewicz MJ; Blizard R; Raven PW
    Int Clin Psychopharmacol; 2010 May; 25(3):132-42. PubMed ID: 20195158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of chlormandinone acetate upon seizures in epileptic children with latent signs of hyperandrogenism].
    Velasco M; Velasco F; Machado J; Cortes-Gallegos V; Peña-Torres A; Parra A
    Arch Invest Med (Mex); 1975; 6(3):477-86. PubMed ID: 53036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The therapeutics of melatonin: a paediatric perspective.
    Gordon N
    Brain Dev; 2000 Jun; 22(4):213-7. PubMed ID: 10838105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melatonin alterations and brain acetylcholine lesions in sleep disorders in Cockayne syndrome.
    Okoshi Y; Tanuma N; Miyata R; Hayashi M
    Brain Dev; 2014 Nov; 36(10):907-13. PubMed ID: 24503446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melatonin for sleep disturbance in children with neurodevelopmental disorders: prospective observational naturalistic study.
    Ayyash HF; Preece P; Morton R; Cortese S
    Expert Rev Neurother; 2015 Jun; 15(6):711-7. PubMed ID: 25938708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary 6-sulphatoxy melatonin excretion during the human menstural cycle.
    Fellenberg AJ; Phillipou G; Seamark RF
    Clin Endocrinol (Oxf); 1982 Jul; 17(1):71-5. PubMed ID: 6889476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A preliminary study on the relationships between diurnal melatonin secretion profile and sleep variables in patients emergently admitted to the coronary care unit.
    Takaesu Y; Futenma K; Kobayashi M; Komada Y; Tanaka N; Yamashina A; Inoue Y
    Chronobiol Int; 2015; 32(6):875-9. PubMed ID: 26102093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential safety issues in the use of the hormone melatonin in paediatrics.
    Kennaway DJ
    J Paediatr Child Health; 2015 Jun; 51(6):584-9. PubMed ID: 25643981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential of melatonin for the treatment or prevention of obesity: an urgent need to include weight reduction as a secondary outcome in clinical trials of melatonin in obese patients with sleep disorders.
    Rastmanesh R; de Bruin PF
    Contemp Clin Trials; 2012 Jul; 33(4):574-5. PubMed ID: 22504344
    [No Abstract]   [Full Text] [Related]  

  • 36. 6-Sulphatoxy melatonin in melancholia.
    Boyce PM
    Am J Psychiatry; 1985 Jan; 142(1):125-7. PubMed ID: 3966574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does hypercalcaemia or calcium antagonism affect human melatonin secretion or renal excretion?
    Wikner J; Wetterberg L; Röjdmark S
    Eur J Clin Invest; 1997 May; 27(5):374-9. PubMed ID: 9179543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Total 24-hour melatonin secretion in adolescent idiopathic scoliosis. A case-control study.
    Fagan AB; Kennaway DJ; Sutherland AD
    Spine (Phila Pa 1976); 1998 Jan; 23(1):41-6. PubMed ID: 9460151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melatonin treatment of non-epileptic myoclonus in children.
    Jan JE; Connolly MB; Hamilton D; Freeman RD; Laudon M
    Dev Med Child Neurol; 1999 Apr; 41(4):255-9. PubMed ID: 10355809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melatonin treatment for sleep disorders in children with neurodevelopmental disorders: an observational study.
    Ross C; Davies P; Whitehouse W
    Dev Med Child Neurol; 2002 May; 44(5):339-44. PubMed ID: 12033720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.